Acridorex

This classification denotes an anorexiant, a preparation that US FDA regulates as an active ingredient or moiety under Unique Ingredient Identifier (SRS UNII) 7SGV5HQH8B. European Medicines Agency schedules Acridorex in its eXtended EudraVigilance Medicinal Product Dictionary or XEVMPD under Index SUB05249MIG. Acridorex generally arises in the molecular formula C24H24N2. The term ACRIDOREX is an International Non-Proprietary Name or INN (see World Health Organization INN reference publication, Volume 23, no. 10 1969, list 9.) ACRIDOREX is scheduled in the U.S. International Trade Commission's Harmonized Tariff System (HTS) Pharmaceutical Appendix. Most nations, for tariff and trade purposes, schedule acridorex under HS 29339990 and SITC 51577. As of Q4 2014, ACRIDOREX remains US FDA's Preferred Term for this commodity. Acridorex bears US NLM identifiers UMLS ID C2699762 and NCI Concept Code C77326. SMILES: N(C(CC1CCCCC1)C)CCC1C2C(NC3C(C2)CCCC3)CCC1.